DOCSLIB.ORG

04/24/2018|Johnson & Johnson: Research Support|Orthopa

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
04/24/2018|Johnson & Johnson: Research Support|Orthopa First Middle Last Disclosure Summary Rene Jorge Abdalla Submitted on: 04/24/2018|Johnson & Johnson: Research support|Orthopaedic Journal of Sports Medicine: Editorial or governing board|Smith & Nephew: Paid presenter or speaker| Amr Atef Abdelgawad Submitted on: 04/04/2018|Springer: IP royalties; Publishing royalties, financial or material support| Salma Abdou (This individual reported nothing to disclose); Submitted on: 01/20/2018 Shehan Abeyewardene (This individual reported nothing to disclose); Submitted on: 12/12/2017 Timothy S Achor Submitted on: 04/19/2018|Globus Medical: Paid consultant|Imagen Technologies: Stock or stock Options|Synthes: Paid consultant| Brian D. Adams Submitted on: 04/29/2018|American Association for Hand Surgery: Board or committee member|Extremity Medical: IP royalties; Paid consultant; Stock or stock Options|Integra Life Sciences: IP royalties; Paid consultant; Research support|Springer - Hand: Editorial or governing board|Wright Medical Technology, Inc.: Paid consultant| John David Adams (This individual reported nothing to disclose); Submitted on: 01/23/2018 Tamer M Ads (This individual reported nothing to disclose); Submitted on: 01/25/2018 Alan M Afsari (This individual reported nothing to disclose); Submitted on: 04/26/2018 Animesh Agarwal Submitted on: 02/17/2018|AAOS: Board or committee member|Acumed, LLC: Research support|AO North America: Paid presenter or speaker|Journal of Orthopaedic Trauma: Editorial or governing board|KCI: Paid consultant; Paid presenter or speaker|Orthopaedic Research Society: Board or committee member|Orthopaedic Trauma Association: Board or committee member|Smith & Nephew: Paid consultant; Paid presenter or speaker; Research support|Springer: Publishing royalties, financial or material support| Sumit Agarwal (This individual reported nothing to disclose); Submitted on: 04/08/2018 Anshul Agarwala (This individual reported nothing to disclose); Submitted on: 01/19/2018 Julie Agel Submitted on: 05/24/2018|Orthopaedic Trauma Association: Board or committee member| Ashok Agrahari (This individual reported nothing to disclose); Submitted on: 04/26/2018 Tashfeen Ahmad (This individual reported nothing to disclose); Submitted on: 09/17/2018 Riaz Ahmed (This individual reported nothing to disclose); Submitted on: 04/27/2018 Jaimo Ahn Submitted on: 04/27/2018|AAOS: Board or committee member|American Board of Orthopaedic Surgery, Inc.: Board or committee member|American Orthopaedic Association: Board or committee member|American Physician Scientists Association: Board or committee member|Cochrane: Publishing royalties, financial or material support|Foundation for Orthopaedic Trauma: Board or committee member|Fronteirs in Surgery: Editorial or governing board|Journal of Orthopaedic Trauma: Editorial or governing board|Merck: Paid consultant|Orthopaedic Research Society: Board or committee member|Orthopaedic Trauma Association: Board or committee member|Skelegen LLC: Stock or stock Options|Synthes: Paid consultant| Ji-Yong Ahn (This individual reported nothing to disclose); Submitted on: 01/24/2018 Nicholas Ahn Submitted on: 04/27/2018|North American Spine Society: Board or committee member|Spine: Editorial or governing board|The Spine Journal: Editorial or governing board|Ulrich: Other financial or material support; Research support| Toshihiro Akisue Submitted on: 02/26/2018|NeoChemir: Research support| Khaled Alabbasi (This individual reported nothing to disclose); Submitted on: 01/21/2018 Zainab Alam (This individual reported nothing to disclose); Submitted on: 04/10/2018 JAMAL ALI ALASIRI (This individual reported nothing to disclose); Submitted on: 09/14/2018 Matthew Albanese Submitted on: 01/26/2018|American Board of Orthopaedic Surgery, Inc.: Board or committee member|Pediatric Orthopaedic Society of North America: Board or committee member| Nicholas Alfonso Submitted on: 01/17/2018|SMV Scientific: Research support| First Middle Last Disclosure Summary Amro Alhoukail (This individual reported nothing to disclose); Submitted on: 05/03/2018 AHMED HASSAN ALHUSSAIN (This individual reported nothing to disclose); Submitted on: 04/18/2018 Jerad Allen (This individual reported nothing to disclose); Submitted on: 06/24/2018 Bashar Alolabi (This individual reported nothing to disclose); Submitted on: 05/15/2018 Joseph Alsousou (This individual reported nothing to disclose); Submitted on: 01/08/2018 Volker Alt Submitted on: 01/17/2018|Injury: Editorial or governing board|Medtronic: Paid consultant| Peter Althausen Submitted on: 01/19/2018|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|Smith & Nephew: Research support|The Orthopedic Implant Company: Stock or stock Options| Daniel T Altman (This individual reported nothing to disclose); Submitted on: 11/13/2017 Gregory T Altman (This individual reported nothing to disclose); Submitted on: 01/11/2018 Helio Jorge Alvachian (This individual reported nothing to disclose); Submitted on: 04/22/2018 Fernandes Mohammad M Alzahrani (This individual reported nothing to disclose); Submitted on: 04/15/2018 Ney Amaral Submitted on: 08/25/2018|Orthopaedic Trauma Association: Board or committee member| Kapil Anand (This individual reported nothing to disclose); Submitted on: 01/29/2018 Braden Anderson (This individual reported nothing to disclose); Submitted on: 01/23/2018 Donald D Anderson Submitted on: 06/01/2018|Iowa Simulation Solutions, LLC: Stock or stock Options| Thomas R E Anderson (This individual reported nothing to disclose); Submitted on: 01/25/2018 Lindsay M. Andras Submitted on: 12/14/2017|Biomet: Paid consultant; Paid presenter or speaker|Eli Lilly: Stock or stock Options|Journal of Pediatric Orthopedics: Editorial or governing board|Medtronic: Paid consultant; Paid presenter or speaker|Nuvasive: Paid consultant; Paid presenter or speaker|Orthobullets: Publishing royalties, financial or material support|Pediatric Orthopaedic Society of North America: Board or committee member|Scoliosis Research Society: Board or committee member|Zimmer: Paid consultant| Arun Aneja (This individual reported nothing to disclose); Submitted on: 05/10/2018 Jeffrey O Anglen (This individual reported nothing to disclose); Submitted on: 06/26/2018 Velarie Ansu (This individual reported nothing to disclose); Submitted on: 01/08/2018 Chris A Anthony (This individual reported nothing to disclose); Submitted on: 09/16/2018 Anand Appalsamy (This individual reported nothing to disclose) Paul T Appleton Submitted on: 05/10/2018|Orthopaedic Trauma Association: Board or committee member| Edgar Araiza (This individual reported nothing to disclose); Submitted on: 05/10/2018 Michael T Archdeacon Submitted on: 05/03/2018|Journal of the American Academy of Orthopaedic Surgeons: Editorial or governing board|Ohio Orthopaedic Soceity: Board or committee member|Orthopaedic Trauma Association: Board or committee member|SLACK Incorporated: Publishing royalties, financial or material support|Stryker: IP royalties; Paid consultant| Kristin Archer Submitted on: 01/28/2018|American Physical Therapy Association: Board or committee member|Foundation for Physical Therapy: Board or committee member|Pacira: Paid consultant|Palladian Health: Paid consultant|Physical Therapy: Editorial or governing board| Jean N Argenson Submitted on: 04/22/2018|Adler-Ortho: Research support|European Knee Society: Board or committee member|Euros: Research support|Graftys, Convatec, Moximed: Board or committee member|Journal of Bone and Joint Surgery - American: Editorial or governing board|Symbios: Research support|Zimmer: IP royalties; Paid consultant; Research support| Connor A Armstrong (This individual reported nothing to disclose); Submitted on: 01/22/2018 Eirini Arvaniti (This individual reported nothing to disclose); Submitted on: 04/19/2018 First Middle Last Disclosure Summary Per Aspenberg Submitted on: 01/15/2018|Acta Orthopaedica: Editorial or governing board|Addbio AB: Stock or stock Options| Naftaly Attias (This individual reported nothing to disclose); Submitted on: 01/20/2018 Basem Attum (This individual reported nothing to disclose); Submitted on: 01/19/2018 Brigham Au Submitted on: 05/09/2018|Smith & Nephew: Paid presenter or speaker| Megan Audet (This individual reported nothing to disclose); Submitted on: 01/26/2018 Peter Augat Submitted on: 04/13/2018|aap: Research support|Aesculap/B.Braun: Research support|Apex Medical: Research support|Archives of Orthopaedic And Trauma Surgery: Editorial or governing board|Arthrex, Inc: Research support|Biomedizinische Technik/Biomedical Engineering: Editorial or governing board|Citieffe: Research support|Deutsche Gesellschaft für Biomechanik: Board or committee member|Deutsche Gesellschaft für Unfallchirurgie: Board or committee member|Eli Lilly: Research support|European Journal of Trauma and Emergency Surgery: Editorial or governing board|International Section Fracture Repair/ORS: Board or committee member|Journal of Orthopaedic Trauma: Editorial or governing board|Orthofix, Inc.: Research support|Orthopaedic Research Society: Board or committee member|Orthopaedic Trauma Association: Board or committee member|Osteosynthesis and Trauma Care Foundation: Board or committee member|Smith & Nephew: Research support|Stryker: Research support|Synthes: Other financial or material support|Ulrich: Other financial or material support| Daniel Austin (This individual reported nothing to disclose); Submitted on: 01/23/2018 Frank R Avilucea Submitted on: 10/02/2018|Orthopaedic Trauma
Load more

Recommended publications
  • March 31, 2021
    Units Cost Market Value US Equity Index Fund US Equities 95.82% Domestic Common Stocks 10X GENOMICS INC 126 10,868 24,673 1LIFE HEALTHCARE INC 145 6,151 4,794 2U INC 101 5,298 4,209 3D SYSTEMS CORP 230 5,461 9,193 3M CO 1,076 182,991 213,726 8X8 INC 156 2,204 4,331 A O SMITH CORP 401 17,703 28,896 A10 NETWORKS INC 58 350 653 AAON INC 82 3,107 5,132 AARON'S CO INC/THE 43 636 1,376 ABBOTT LABORATORIES 3,285 156,764 380,830 ABBVIE INC 3,463 250,453 390,072 ABERCROMBIE & FITCH CO 88 2,520 4,086 ABIOMED INC 81 6,829 25,281 ABM INDUSTRIES INC 90 2,579 3,992 ACACIA RESEARCH CORP 105 1,779 710 ACADIA HEALTHCARE CO INC 158 8,583 9,915 ACADIA PHARMACEUTICALS INC 194 6,132 4,732 ACADIA REALTY TRUST 47 1,418 1,032 ACCELERATE DIAGNOSTICS INC 80 1,788 645 ACCELERON PHARMA INC 70 2,571 8,784 ACCO BRANDS CORP 187 1,685 1,614 ACCURAY INC 64 483 289 ACI WORLDWIDE INC 166 3,338 6,165 ACTIVISION BLIZZARD INC 1,394 52,457 133,043 ACUITY BRANDS INC 77 13,124 14,401 ACUSHNET HOLDINGS CORP 130 2,487 6,422 ADAPTHEALTH CORP 394 14,628 10,800 ADAPTIVE BIOTECHNOLOGIES CORP 245 11,342 10,011 ADOBE INC 891 82,407 521,805 ADT INC 117 716 1,262 ADTALEM GLOBAL EDUCATION INC 99 4,475 3,528 ADTRAN INC 102 2,202 2,106 ADVANCE AUTO PARTS INC 36 6,442 7,385 ADVANCED DRAINAGE SYSTEMS INC 116 3,153 13,522 ADVANCED ENERGY INDUSTRIES INC 64 1,704 7,213 ADVANCED MICRO DEVICES INC 2,228 43,435 209,276 ADVERUM BIOTECHNOLOGIES INC 439 8,321 1,537 AECOM 283 12,113 17,920 AERIE PHARMACEUTICALS INC 78 2,709 1,249 AERSALE CORP 2,551 30,599 31,785 AES CORP/THE 1,294 17,534 33,735 AFFILIATED
    [Show full text]
  • Marriage Certificates
    GROOM LAST NAME GROOM FIRST NAME BRIDE LAST NAME BRIDE FIRST NAME DATE PLACE Abbott Calvin Smerdon Dalkey Irene Mae Davies 8/22/1926 Batavia Abbott George William Winslow Genevieve M. 4/6/1920Alabama Abbotte Consalato Debale Angeline 10/01/192 Batavia Abell John P. Gilfillaus(?) Eleanor Rose 6/4/1928South Byron Abrahamson Henry Paul Fullerton Juanita Blanche 10/1/1931 Batavia Abrams Albert Skye Berusha 4/17/1916Akron, Erie Co. Acheson Harry Queal Margaret Laura 7/21/1933Batavia Acheson Herbert Robert Mcarthy Lydia Elizabeth 8/22/1934 Batavia Acker Clarence Merton Lathrop Fannie Irene 3/23/1929East Bethany Acker George Joseph Fulbrook Dorothy Elizabeth 5/4/1935 Batavia Ackerman Charles Marshall Brumsted Isabel Sara 9/7/1917 Batavia Ackerson Elmer Schwartz Elizabeth M. 2/26/1908Le Roy Ackerson Glen D. Mills Marjorie E. 02/06/1913 Oakfield Ackerson Raymond George Sherman Eleanora E. Amelia 10/25/1927 Batavia Ackert Daniel H. Fisher Catherine M. 08/08/1916 Oakfield Ackley Irving Amos Reid Elizabeth Helen 03/17/1926 Le Roy Acquisto Paul V. Happ Elsie L. 8/27/1925Niagara Falls, Niagara Co. Acton Robert Edward Derr Faith Emma 6/14/1913Brockport, Monroe Co. Adamowicz Ian Kizewicz Joseta 5/14/1917Batavia Adams Charles F. Morton Blanche C. 4/30/1908Le Roy Adams Edward Vice Jane 4/20/1908Batavia Adams Edward Albert Considine Mary 4/6/1920Batavia Adams Elmer Burrows Elsie M. 6/6/1911East Pembroke Adams Frank Leslie Miller Myrtle M. 02/22/1922 Brockport, Monroe Co. Adams George Lester Rebman Florence Evelyn 10/21/1926 Corfu Adams John Benjamin Ford Ada Edith 5/19/1920Batavia Adams Joseph Lawrence Fulton Mary Isabel 5/21/1927Batavia Adams Lawrence Leonard Boyd Amy Lillian 03/02/1918 Le Roy Adams Newton B.
    [Show full text]
  • L'institution Royale Pour L'avancement
    L’INSTITUTION ROYALE POUR L’AVANCEMENT DES SCIENCES / UNIVERSITÉ McGILL ACTIONS AMÉRICAINES │ au 31 mars 2019 Actions américaines d’une valeur supérieure à 500 000 $ cotées en bourse et détenues dans des comptes distincts (en $ CAN) GRAND CANYON EDUCATION INC 2 464 502 WADDELL & REED FINANCIAL INC 838 294 VIRTU FINANCIAL INC 2 098 163 DXP ENTERPRISES INC/TX 829 531 EURONET WORLDWIDE INC 2 075 232 OSHKOSH CORP 772 848 IRIDIUM COMMUNICATIONS INC 2 021 967 CIENA CORP 748 266 MARKETAXESS HOLDINGS INC 1 969 545 SNAP‐ON INC 710 950 UNIVERSAL HEALTH SERVICES INC 1 924 707 PULTEGROUP INC 705 975 MAXIMUS INC 1 697 760 VISHAY INTERTECHNOLOGY INC 703 237 ENVESTNET INC 1 539 593 UNUM GROUP 659 850 CHARLES RIVER LABORATORIES INT 1 531 805 LEAR CORP 652 686 CHEMED CORP 1 484 619 JETBLUE AIRWAYS CORP 649 127 MARRIOTT VACATIONS WORLDWIDE C 1 442 976 AVNET INC 643 136 US SILICA HOLDINGS INC 1 434 222 AMC NETWORKS INC 636 960 ACUSHNET HOLDINGS CORP 1 352 421 HUNTINGTON INGALLS INDUSTRIES 636 660 GENTHERM INC 1 321 685 WESTROCK CO 635 298 LAUREATE EDUCATION INC 1 308 706 CIT GROUP INC 628 038 FOX FACTORY HOLDING CORP 1 274 121 DOMTAR CORP 623 501 HURON CONSULTING GROUP INC 1 242 872 REGIONS FINANCIAL CORP 614 370 INTL. FCSTONE INC 1 242 806 ARBOR REALTY TRUST INC 608 950 RE/MAX HOLDINGS INC 1 238 584 QUEST DIAGNOSTICS INC 600 643 TEMPUR SEALY INTERNATIONAL INC 1 225 928 OWENS CORNING 598 025 GLOBUS MEDICAL INC 1 212 789 GLOBAL BRASS & COPPER HOLDINGS 593 531 THERMON GROUP HOLDINGS INC 1 209 830 FEDERAL AGRICULTURAL MORTGAGE 590 253 SHUTTERSTOCK INC 1 202
    [Show full text]
  • BNYM Investment Port:Midcap Stock Port (Unaudited) As of Date: 09/30/2020 Common Stocks
    BNYM Investment Port:MidCap Stock Port (Unaudited) As of date: 09/30/2020 Common Stocks Identifier Security Description Shares Market Value ($) 002535300 Aaron's 7,450 422,043 00404A109 Acadia Healthcare 5,480 161,550 004498101 ACI Worldwide 13,250 346,223 00508Y102 Acuity Brands 9,470 969,255 BD845X2 Adient 12,480 216,278 00737L103 Adtalem Global Education 6,800 166,872 00766T100 AECOM 4,170 174,473 018581108 Alliance Data Systems 7,130 299,317 01973R101 Allison Transmission Holdings 7,110 249,845 00164V103 AMC Networks 10,710 264,644 023436108 Amedisys 2,760 652,547 025932104 American Financial Group 3,310 221,704 03073E105 AmerisourceBergen 2,220 215,162 042735100 Arrow Electronics 5,620 442,069 04280A100 Arrowhead Pharmaceuticals 5,670 244,150 045487105 Associated Banc-Corp 47,940 605,003 05329W102 Autonation 6,980 369,451 05368V106 Avient 23,030 609,374 053774105 Avis Budget Group 10,600 278,992 05464C101 Axon Enterprise 2,410 218,587 062540109 Bank of Hawaii 4,830 244,012 06417N103 Bank OZK 6,630 141,352 090572207 Bio-Rad Laboratories 1,480 762,881 09073M104 Bio-Techne 880 218,002 05550J101 BJs Wholesale Club Holdings 11,270 468,269 09227Q100 Blackbaud 3,750 209,363 103304101 Boyd Gaming 18,350 563,162 105368203 Brandywine Realty Trust 93,500 966,790 11120U105 Brixmor Property Group 6,300 73,647 117043109 Brunswick 8,150 480,117 12685J105 Cable One 300 565,629 127190304 CACI International, Cl. A 3,980 848,377 12769G100 Caesars Entertainment 11,890 666,553 133131102 Camden Property Trust 11,390 1,013,482 134429109 Campbell Soup 4,440
    [Show full text]
  • CONGRESSIONAL RECORD—SENATE, Vol. 155, Pt. 7 8573 ORDER for ADJOURNMENT Health Care Policies in the Senate That Do Play a Crucial Role in This Nation’S Mr
    March 25, 2009 CONGRESSIONAL RECORD—SENATE, Vol. 155, Pt. 7 8573 ORDER FOR ADJOURNMENT health care policies in the Senate that do play a crucial role in this Nation’s Mr. DURBIN. Mr. President, if there apply specifically to rural commu- mental health care. is no further business to come before nities. I am proud to join her as we These providers go through rigorous the Senate, I ask unanimous consent it fight to ensure Medicare patients liv- training, and it is similar to the cur- stand adjourned under the previous ing in rural and in frontier States have riculum of a master’s level social order following the remarks of Senator access to and a choice of their mental worker. They must not be excluded BARRASSO. health professionals. from the Medicare Program. I believe The PRESIDING OFFICER. Without The Seniors Mental Health Access S. 671 is critically important to the objection, it is so ordered. Improvement Act will permit marriage health and the well-being of our Na- Mr. DURBIN. Mr. President, I sug- and family therapists and licensed pro- tion’s seniors. It is time for this bill to gest the absence of a quorum. fessional counselors to bill Medicare become law. The PRESIDING OFFICER. The directly. These providers will then re- I yield the floor. clerk will call the roll. ceive 75 percent of the rate that psychi- f The legislative clerk proceeded to atrists and psychologists receive for the same services. ADJOURNMENT UNTIL 9:30 A.M. call the roll. TOMORROW Mr. BARRASSO. Mr. President, I ask I want my colleagues to know that S.
    [Show full text]
  • Usef-I Q2 2021
    Units Cost Market Value U.S. EQUITY FUND-I U.S. Equities 88.35% Domestic Common Stocks 10X GENOMICS INC 5,585 868,056 1,093,655 1ST SOURCE CORP 249 9,322 11,569 2U INC 301 10,632 12,543 3D SYSTEMS CORP 128 1,079 5,116 3M CO 11,516 2,040,779 2,287,423 A O SMITH CORP 6,897 407,294 496,998 AARON'S CO INC/THE 472 8,022 15,099 ABBOTT LABORATORIES 24,799 2,007,619 2,874,948 ABBVIE INC 17,604 1,588,697 1,982,915 ABERCROMBIE & FITCH CO 1,021 19,690 47,405 ABIOMED INC 9,158 2,800,138 2,858,303 ABM INDUSTRIES INC 1,126 40,076 49,938 ACACIA RESEARCH CORP 1,223 7,498 8,267 ACADEMY SPORTS & OUTDOORS INC 1,036 35,982 42,725 ACADIA HEALTHCARE CO INC 2,181 67,154 136,858 ACADIA REALTY TRUST 1,390 24,572 30,524 ACCO BRANDS CORP 1,709 11,329 14,749 ACI WORLDWIDE INC 6,138 169,838 227,965 ACTIVISION BLIZZARD INC 13,175 839,968 1,257,422 ACUITY BRANDS INC 1,404 132,535 262,590 ACUSHNET HOLDINGS CORP 466 15,677 23,020 ADAPTHEALTH CORP 1,320 39,475 36,181 ADAPTIVE BIOTECHNOLOGIES CORP 18,687 644,897 763,551 ADDUS HOMECARE CORP 148 13,034 12,912 ADOBE INC 5,047 1,447,216 2,955,725 ADT INC 3,049 22,268 32,899 ADTALEM GLOBAL EDUCATION INC 846 31,161 30,151 ADTRAN INC 892 10,257 18,420 ADVANCE AUTO PARTS INC 216 34,544 44,310 ADVANCED DRAINAGE SYSTEMS INC 12,295 298,154 1,433,228 ADVANCED MICRO DEVICES INC 14,280 895,664 1,341,320 ADVANSIX INC 674 15,459 20,126 ADVANTAGE SOLUTIONS INC 1,279 14,497 13,800 ADVERUM BIOTECHNOLOGIES INC 1,840 7,030 6,440 AECOM 5,145 227,453 325,781 AEGLEA BIOTHERAPEUTICS INC 287 1,770 1,998 AEMETIS INC 498 6,023 5,563 AERSALE CORP
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington Large-Cap Strategy Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS APPLE INC 4.97% MICROSOFT CORP 4.69% AMAZON.COM INC 3.45% FACEBOOK INC 1.99% ALPHABET INC 1.80% ALPHABET INC 1.77% BERKSHIRE HATHAWAY INC 1.48% JPMORGAN CHASE & CO 1.35% TESLA INC 1.20% JOHNSON & JOHNSON 1.12% UNITEDHEALTH GROUP INC 0.98% VISA INC 0.96% NVIDIA CORP 0.96% BANK OF AMERICA CORP 0.89% HOME DEPOT INC/THE 0.87% WALT DISNEY CO/THE 0.82% MASTERCARD INC 0.80% PAYPAL HOLDINGS INC 0.77% EXXON MOBIL CORP 0.68% PROCTER & GAMBLE CO/THE 0.67% COMCAST CORP 0.66% ADOBE INC 0.62% INTEL CORP 0.59% VERIZON COMMUNICATIONS INC 0.59% CISCO SYSTEMS INC 0.57% CHEVRON CORP 0.55% PFIZER INC 0.54% NETFLIX INC 0.54% AT&T INC 0.53% SALESFORCE.COM INC 0.53% ABBOTT LABORATORIES 0.51% ABBVIE INC 0.50% MERCK & CO INC 0.48% WELLS FARGO & CO 0.48% BROADCOM INC 0.47% THERMO FISHER SCIENTIFIC INC 0.47% ACCENTURE PLC 0.46% CITIGROUP INC 0.45% MCDONALD'S CORP 0.44% TEXAS INSTRUMENTS INC 0.44% COCA-COLA CO/THE 0.44% HONEYWELL INTERNATIONAL INC 0.44% LINDE PLC 0.43% MEDTRONIC PLC 0.43% NIKE INC 0.43% ELI LILLY & CO 0.42% PEPSICO INC 0.42% UNITED PARCEL SERVICE INC 0.41% WALMART INC 0.40% DANAHER CORP 0.40% UNION PACIFIC CORP 0.40% QUALCOMM INC 0.38% BRISTOL-MYERS SQUIBB CO 0.37% ORACLE CORP 0.37% LOWE'S COS INC 0.36% BLACKROCK INC 0.35% CATERPILLAR INC 0.35% AMGEN INC 0.35% BOEING CO/THE 0.35% MORGAN STANLEY 0.35% COSTCO WHOLESALE CORP 0.35% RAYTHEON TECHNOLOGIES CORP 0.34% STARBUCKS CORP 0.34% GOLDMAN SACHS GROUP INC/THE 0.34% GENERAL ELECTRIC
    [Show full text]
  • UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT of FLORIDA Miami Division in Re: MIAMI INTERNATIONAL MEDI
    Case 18-12741-LMI Doc 97 Filed 04/03/18 Page 1 of 23 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA Miami Division www.flsb.uscourts.gov In re: MIAMI INTERNATIONAL MEDICAL CENTER, LLC1 Case No. 18-12741-LMI d/b/a THE MIAMI MEDICAL CENTER, Chapter 11 Debtor. / SUPPLEMENTAL CERTIFICATE OF SERVICE I HEREBY CERTIFY that a true and correct copy of the Debtor’s Motion for Entry of (A) an Order Approving Bidding Procedures, (B) Approving Certain Protections to Stalking Horse Purchaser, (C) Approving Notice Procedures, and (D) an Order (I) Approving the Asset Purchase Agreement, (II) Authorizing the Sale of all or Substantially all of the Assets of the Debtor Free and Clear of all Liens, Claims, Encumbrances and Other Interests, (III) Authorizing the Assumption and Assignment of Certain Executory Contracts and Unexpired Leases, (IV) Scheduling Dates to Conduct Auction and Hearing to Consider Final Approval of Sale, and (V) Granting Related Relief [ECF No. 84] was served via Regular U.S. Mail on April 2, 2018, on all REMAINDER OF PAGE LEFT INTENTIONALLY BLANK 1The Debtor’s current mailing address is 5959 NW 7 St, Miami, FL 33126 and its EIN ends 4362. 1 LAW OFFICES OF MELAND RUSSIN & BUDWICK, P.A. 3200 SOUTHEAST FINANCIAL CENTER, 200 SOUTH BISCAYNE BOULEVARD, MIAMI, FLORIDA 33131 • TELEPHONE (305) 358-6363 Case 18-12741-LMI Doc 97 Filed 04/03/18 Page 2 of 23 parties listed on the Court’s Matrix attached hereto as Exhibit 12, and to all parties listed on the Patients Matrix which was filed under seal pursuant to Court Order [ECF No.
    [Show full text]
  • 1St Quarter 2014 FINAL BOOK
    SCOTT-MACON HEALTHCARE REVIEW: FIRST QUARTER 2014 Healthcare Overview, Mean Revenue Multiples 2 Healthcare Overview, Mean EBITDA Multiples 4 Analysis of Selected Healthcare 6 Merger and Acquisition Transactions January 1—March 31, 2014 Analysis of Selected 22 CONTENTS Publicly-Traded Healthcare Companies SCOTT-MACON Healthcare Investment Banking 2 FIRST QUARTER 2014 HEALTHCARE REVIEW Dear Clients and Friends, Scott-Macon is pleased to present our quar- quisition of an Oklahoma health insurer by an invest- terly Healthcare Review covering the first quarter of ment firm, perhaps indicating that the perceived op- 2014. If you haven’t done so already, please email me portunities in this sector are now more significant at [email protected] to automatically con- than the potential pitfalls now that the Affordable tinue receiving our publications in the future as we Care Act is in full swing. Turning to Technology, are transitioning to digital publishing with email dis- once again we are seeing an incredibly diverse group tribution. of acquirors attracted to Healthcare Technology com- Pages four and five represent a visual snapshot panies—international companies, medical equipment of the average multiples for all of the healthcare, makers, private equity/investment firms and their medical and pharmaceutical transactions that either portfolio companies, and of course other Healthcare closed or were announced during the first quarter, (as well as Non-Healthcare) Technology companies, along with the average multiples for the major pub- both publicly-traded and privately-held. Outsourcing licly-traded healthcare, medical and pharmaceutical companies witnessed one of the busiest quarters we companies. have ever seen for this segment, a perennial favorite due to the inherent growth characteristics of the in- In the Insurance sector, there were two deals of dustry and the opportunities to create efficiencies for note in the First Quarter: the merger of two of the providers, payors and product companies as well.
    [Show full text]
  • 1986 Surname
    Surname Given Age Date Page Maiden Note Abegg Missel 88 15-Dec C-8 Abernathy Manuel 79 1-Jan C-5 Abner Tom 71 24-Jun B-7 Abraham Aloysius J. 77 24-Jul C-2 Abram Harold Glenn 75 14-Sep D-2 Abramson Frances L. 46 28-Dec C-7 Levine Ackerman Mary 79 16-Sep B-7 Adam Paul T. 76 10-Sep C-5 Adams Claude 78 20-Jan A-5 Adams Gloria L. 48 23-Sep D-6 Adams Irene 77 21-Aug C-3 Adams Martha 72 3-Nov C-1 Adank Gerald C. 65 1-Dec C-8 Veteran of World War II Adkins Johnnie Lee 78 13-Feb B-9 Adley Daisy A. 93 2-Sep D-7 Ahlborn Raymond W. 73 2-May C-1 Aird Gordon R. 77 21-Nov D-1 See article, p. D-1 Aitken Marion 70 1-Jul B-7 Aksentijevic Martha 56 17-Sep B-8 Alamillo Nora 75 4-Feb C-1 Albert Lester E. 65 30-Sep B-7 Albrecht Victoria A. 84 3-Jan A-7 Aldrin Raymond E. 71 11-Aug B-5 Aleksandrovic Ivan 76 11-Dec B-13 Aleksandrovic Jelena 79 2-Dec C-1 Ales Francis J. 69 31-Mar B-8 Alexander Janet 49 28-Jul C-1 Alexander Penny C. 60 24-Mar C-1 Alexander Terry 53 9-Dec C-1 Alexander Vera (Cook) 2-Dec C-1 Alexander William A. 50 27-Dec C-2 Alfaro Mark A. 21 5-Feb D-1 Alger Kenneth H.
    [Show full text]
  • Final Program
    2014 ANNUAL MEETING Welcome UPCOMING MEETINGS 11th Annual International Pediatric Orthopaedic Symposium December 3-6, 2014 – Orlando, FL Presented by POSNA and AAOS POSNA Specialty Day March 28, 2015 – Las Vegas, Nevada POSNA 2015 Annual Meeting and Pre-Course April 29 – May 2, 2015 Marriott Marquis – Atlanta, Georgia Acknowledgments The Pediatric Orthopaedic Society of North America gratefully acknowledges the following for their generous financial support during 2014: Howard Steel Foundation St. Giles Foundation Angela S.M. Kuo Memorial Fund Double Diamond Level K2M* Medtronic* OrthoPediatrics* Diamond Level DePuy Synthes* Stryker* Platinum Level Biomet Spine/Trauma* Shriners Hospitals for Children Gold Level Arthrex, Inc. BioMarin Pharmaceutical Inc. Globus Medical Medicrea, USA* Pega Medical* Wright Medical Silver Level Alphatec Spine* Ellipse Technologies, Inc. Orthofix* *Provided financial support for the 2014 Annual Meeting Thank-2- You On behalf of our local host, David Skaggs and his wife Val Ulene, we welcome you to Hollywood and the 2014 POSNA Annual Meeting. Many POSNA volunteers and staff Welcomehave been working hard to make our experience in Hollywood spectacular. The meeting opens on Wednesday morning with the pre-course entitled “Quality, Safety, Value: From Theory to Practice Management.” Min Kocher has enlisted experts both inside and outside of POSNA to help all of us understand how the changing healthcare environment and a focus on quality and value will affect our practice. The scientific sessions begin Wednesday afternoon: Todd Milbrandt and his program committee have assembled some of the high- est rated papers submitted into an outstanding quality and value session that will help your patients. The opening ceremony on Wednesday evening allows us to recognize our industry spon- sors and the outstanding achievement of several of our members.
    [Show full text]
  • SUMMER 2017 — PAGE 1 the Life Sciences Executive Network at the Sarian Group Presents Biotech Bulletin | Summer 2017
    BIOTECH BULLETIN SUMMER 2017 — PAGE 1 The Life Sciences Executive Network At The Sarian Group Presents Biotech Bulletin | Summer 2017 Tracking The Pulse Of The Philadelphia Life Sciences Industry Table Of Contents Stay up to date on the pulse of the Philadelphia Life Sciences industry with our Biotech 1. Government Interference Bulletin. This is a quarterly newsletter, with data and perspectives from local leaders Unnecessary in Medicare within the industry. Greg Sarian of The Sarian Group is the author of the Biotech Bulletin. Drug-Pricing Process By Ted Piper, Director, Bravo Group Each issue will include insight on the latest industry trends, performance metrics on local biotech companies as well as current acquisitions and IPO news in this area. 2. Emerging Trends to Improve Productivity in Drug Development By Jeffrey J. DiFrancesco, Founder & Government Interference Unnecessary in Medicare Drug- Executive Director, Avancer Group Inc. Pricing Process 3. A Spotlight on Trovita Health Science By Ted Piper, Director, Bravo Group A conversation with Mr. Will Brown We’ve all heard the same question when it comes to prescription drug 4. Pre-Transaction Planning Considerations Before a prices under Medicare Part D: Why can’t the government negotiate Transaction prices? By Greg Sarian, CPWA®, CIMA® , CFP® , ChFC® , CEPA® The funny thing is that prices are negotiated — just not by the government. 5. The Sarian Group Index Medicare Part D allows private insurers to bargain with pharmaceutical companies for 6. Philly Fundings discounts and rebates so that enrollees can enjoy the lower prices through a third party called pharmacy benefit managers. And it’s been successful, netting discounts of 30 percent to 50 percent of list prices.
    [Show full text]